Organogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary

Organogenesis Holdings

01/03/2023 22:05

* Organogenesis Holdings Inc  ORGO.OQ  reported quarterly
adjusted
earnings of 6 cents​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was
for earnings of 5 cents per share.
    * Revenue fell 10.1% to $115.52 million from a year ago;
analysts
expected $122.40 million. 
    * Organogenesis Holdings Inc's reported EPS for the quarter
was 6
cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Organogenesis Holdings Inc shares had fallen by 8.9% this
quarter.
    * The company reported quarterly net income of $7.49
million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 10:05 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.05           0.06           Beat
 Sep. 30 2022      0.06           0.00           Missed
 Jun. 30 2022      0.08           0.07           Missed
 Mar. 31 2022      0.05           0.00           Missed